Patient-Reported Quality of Life After Hypofractionated Versus Conventional Adjuvant Radiotherapy for Stage IIB–IIIC Breast Cancer: A Prospective 12-Month Cohort Study from Uzbekistan

Authors
Category Primary study
JournalNat. Res. Hum. Health.
Year 2026
This article has no abstract
Epistemonikos ID: 7e61f202518af8b6f6d322303c465fec186e03b3
First added on: Oct 24, 2026